2024-09-01 2025-08-31 false Capium Accounts Production 1.1 12177626 2024-09-01 2025-08-31 12177626 bus:AbridgedAccounts 2024-09-01 2025-08-31 12177626 bus:FRS102 2024-09-01 2025-08-31 12177626 bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 12177626 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 12177626 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 12177626 2024-09-01 2025-08-31 12177626 2025-08-31 12177626 bus:RegisteredOffice 2024-09-01 2025-08-31 12177626 core:WithinOneYear 2025-08-31 12177626 core:AfterOneYear 2025-08-31 12177626 1 2024-09-01 2025-08-31 12177626 bus:Director1 2024-09-01 2025-08-31 12177626 bus:Director1 2025-08-31 12177626 bus:Director1 2023-09-01 2024-08-31 12177626 2023-09-01 12177626 bus:LeadAgentIfApplicable 2024-09-01 2025-08-31 12177626 2023-09-01 2024-08-31 12177626 2024-08-31 12177626 core:WithinOneYear 2024-08-31 12177626 core:AfterOneYear 2024-08-31 12177626 bus:EntityAccountantsOrAuditors 2023-09-01 2024-08-31 12177626 bus:OrdinaryShareClass1 2024-09-01 2025-08-31 12177626 bus:OrdinaryShareClass1 2025-08-31 12177626 bus:OrdinaryShareClass1 2023-09-01 2024-08-31 12177626 bus:OrdinaryShareClass1 2024-08-31 12177626 core:ComputerEquipment 2024-09-01 2025-08-31 12177626 core:ComputerEquipment 2025-08-31 12177626 core:ComputerEquipment 2024-08-31 12177626 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-08-31 12177626 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-08-31 12177626 core:CostValuation core:Non-currentFinancialInstruments 2025-08-31 12177626 core:CostValuation core:Non-currentFinancialInstruments 2024-08-31 12177626 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-08-31 12177626 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 12177626 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 12177626 core:Non-currentFinancialInstruments 2025-08-31 12177626 core:Non-currentFinancialInstruments 2024-08-31 12177626 core:ShareCapital 2025-08-31 12177626 core:ShareCapital 2024-08-31 12177626 core:RetainedEarningsAccumulatedLosses 2025-08-31 12177626 core:RetainedEarningsAccumulatedLosses 2024-08-31 12177626 dpl:Item1 2024-09-01 12177626 dpl:Item1 2025-08-31 12177626 dpl:Item1 2023-09-01 12177626 dpl:Item1 2024-08-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 12177626
England and Wales
CONNECTATHERAPY LTD
Abridged Accounts
Period of accounts Start date: 01 September 2024 End date: 31 August 2025

CONNECTATHERAPY LTD Contents Page For the year ended 31 August 2025
Statement of financial position | 1
Notes to the financial statements | 2

CONNECTATHERAPY LTD Statement of Financial Position As at 31 August 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Tangible fixed assets | 3 | 13,233 |  | 13,233
|  | 13,233 |  | 13,233
Current assets |  |  |
Cash at bank and in hand |  | 1,828 |  | 1,828
Creditors: amount falling due within one year |  | (27,316) |  | (27,316)
Net current assets |  | (25,488) |  | (25,488)
Total assets less current liabilities |  | (12,255) |  | (12,255)
Net assets |  | (12,255) |  | (12,255)
Capital and reserves |  |  |
Called up share capital | 4 | 100 |  | 100
Profit and loss account |  | (12,355) |  | (12,355)
Shareholders' funds |  | (12,255) |  | (12,255)
For the year ended 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the director on 15 May 2026 and were signed by:
------------------------------- Fatema Shirin Mawji Director
1

CONNECTATHERAPY LTD Notes to the Abridged Financial Statements For the year ended 31 August 2025
General Information CONNECTATHERAPY LTD is a private company, limited by shares, registered in England and Wales, registration number 12177626, registration address 110 Carlton Ave East, Wembley, Middlesex, HA9 8LY. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment | 25% Reducing Balance
2. | Average number of employees Average number of employees during the year was 1 (2024 : 1).
3. | Tangible fixed assets
Cost or valuation | Computer Equipment |  | Total
| £ |  | £
At 01 September 2024 | 13,233 |  | 13,233
Additions | - |  | -
Disposals | - |  | -
At 31 August 2025 | 13,233 |  | 13,233
Depreciation
At 01 September 2024 | - |  | -
Charge for year | - |  | -
On disposals | - |  | -
At 31 August 2025 | - |  | -
Net book values
Closing balance as at 31 August 2025 | 13,233 |  | 13,233
Opening balance as at 01 September 2024 | 13,233 |  | 13,233
4. | Share Capital
Allotted, called up and fully paid | 2025 £ |  | 2024 £
--- | --- | --- | ---
100 Class A shares of £1.00 each | 100 |  | 100
| 100 |  | 100
2